Therapeutic Radioisotopes Market Report

Global Therapeutic Radioisotopes Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 02, 2022
  • PAGES：193
  • REPORT CODE：GMM788983
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

    Therapeutic Radioisotopes market report explains the definition, types, applications, major countries, and major players of the Therapeutic Radioisotopes market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Spectrum Pharmaceuticals

    • Dongcheng

    • Q BioMed

    • Bayer

    • International Isotopes

    • Novartis

    • China Isotope & Radiation

    • Progenics Pharmaceuticals

    • Jubilant DraxImage

    • Curium Pharmaceuticals

    • Lantheus

    By Type:

    • Radium-223

    • Lutetium-177

    • Iodine-131

    • Other

    By End-User:

    • Thyroid

    • Bone Metastasis

    • Lymphoma

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Therapeutic Radioisotopes Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Therapeutic Radioisotopes Outlook to 2028- Original Forecasts

    • 2.2 Therapeutic Radioisotopes Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Therapeutic Radioisotopes Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Therapeutic Radioisotopes Market- Recent Developments

    • 6.1 Therapeutic Radioisotopes Market News and Developments

    • 6.2 Therapeutic Radioisotopes Market Deals Landscape

    7 Therapeutic Radioisotopes Raw Materials and Cost Structure Analysis

    • 7.1 Therapeutic Radioisotopes Key Raw Materials

    • 7.2 Therapeutic Radioisotopes Price Trend of Key Raw Materials

    • 7.3 Therapeutic Radioisotopes Key Suppliers of Raw Materials

    • 7.4 Therapeutic Radioisotopes Market Concentration Rate of Raw Materials

    • 7.5 Therapeutic Radioisotopes Cost Structure Analysis

      • 7.5.1 Therapeutic Radioisotopes Raw Materials Analysis

      • 7.5.2 Therapeutic Radioisotopes Labor Cost Analysis

      • 7.5.3 Therapeutic Radioisotopes Manufacturing Expenses Analysis

    8 Global Therapeutic Radioisotopes Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Therapeutic Radioisotopes Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Therapeutic Radioisotopes Export by Region (Top 10 Countries) (2017-2028)

    9 Global Therapeutic Radioisotopes Market Outlook by Types and Applications to 2022

    • 9.1 Global Therapeutic Radioisotopes Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Radium-223 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Lutetium-177 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Iodine-131 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Therapeutic Radioisotopes Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Thyroid Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Bone Metastasis Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Lymphoma Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Therapeutic Radioisotopes Market Analysis and Outlook till 2022

    • 10.1 Global Therapeutic Radioisotopes Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.2.2 Canada Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.2.3 Mexico Therapeutic Radioisotopes Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.3.2 UK Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.3.3 Spain Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.3.4 Belgium Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.3.5 France Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.3.6 Italy Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.3.7 Denmark Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.3.8 Finland Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.3.9 Norway Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.3.10 Sweden Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.3.11 Poland Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.3.12 Russia Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.3.13 Turkey Therapeutic Radioisotopes Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.4.2 Japan Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.4.3 India Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.4.4 South Korea Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.4.5 Pakistan Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.4.6 Bangladesh Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.4.7 Indonesia Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.4.8 Thailand Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.4.9 Singapore Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.4.10 Malaysia Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.4.11 Philippines Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.4.12 Vietnam Therapeutic Radioisotopes Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.5.2 Colombia Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.5.3 Chile Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.5.4 Argentina Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.5.5 Venezuela Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.5.6 Peru Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.5.7 Puerto Rico Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.5.8 Ecuador Therapeutic Radioisotopes Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.6.2 Kuwait Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.6.3 Oman Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.6.4 Qatar Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Therapeutic Radioisotopes Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.7.2 South Africa Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.7.3 Egypt Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.7.4 Algeria Therapeutic Radioisotopes Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Therapeutic Radioisotopes Consumption (2017-2022)

      • 10.8.2 New Zealand Therapeutic Radioisotopes Consumption (2017-2022)

    11 Global Therapeutic Radioisotopes Competitive Analysis

    • 11.1 Spectrum Pharmaceuticals

      • 11.1.1 Spectrum Pharmaceuticals Company Details

      • 11.1.2 Spectrum Pharmaceuticals Therapeutic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Spectrum Pharmaceuticals Therapeutic Radioisotopes Main Business and Markets Served

      • 11.1.4 Spectrum Pharmaceuticals Therapeutic Radioisotopes Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Dongcheng

      • 11.2.1 Dongcheng Company Details

      • 11.2.2 Dongcheng Therapeutic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Dongcheng Therapeutic Radioisotopes Main Business and Markets Served

      • 11.2.4 Dongcheng Therapeutic Radioisotopes Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Q BioMed

      • 11.3.1 Q BioMed Company Details

      • 11.3.2 Q BioMed Therapeutic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Q BioMed Therapeutic Radioisotopes Main Business and Markets Served

      • 11.3.4 Q BioMed Therapeutic Radioisotopes Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Bayer

      • 11.4.1 Bayer Company Details

      • 11.4.2 Bayer Therapeutic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Bayer Therapeutic Radioisotopes Main Business and Markets Served

      • 11.4.4 Bayer Therapeutic Radioisotopes Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 International Isotopes

      • 11.5.1 International Isotopes Company Details

      • 11.5.2 International Isotopes Therapeutic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 International Isotopes Therapeutic Radioisotopes Main Business and Markets Served

      • 11.5.4 International Isotopes Therapeutic Radioisotopes Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Novartis

      • 11.6.1 Novartis Company Details

      • 11.6.2 Novartis Therapeutic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Novartis Therapeutic Radioisotopes Main Business and Markets Served

      • 11.6.4 Novartis Therapeutic Radioisotopes Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 China Isotope & Radiation

      • 11.7.1 China Isotope & Radiation Company Details

      • 11.7.2 China Isotope & Radiation Therapeutic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 China Isotope & Radiation Therapeutic Radioisotopes Main Business and Markets Served

      • 11.7.4 China Isotope & Radiation Therapeutic Radioisotopes Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Progenics Pharmaceuticals

      • 11.8.1 Progenics Pharmaceuticals Company Details

      • 11.8.2 Progenics Pharmaceuticals Therapeutic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Progenics Pharmaceuticals Therapeutic Radioisotopes Main Business and Markets Served

      • 11.8.4 Progenics Pharmaceuticals Therapeutic Radioisotopes Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Jubilant DraxImage

      • 11.9.1 Jubilant DraxImage Company Details

      • 11.9.2 Jubilant DraxImage Therapeutic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Jubilant DraxImage Therapeutic Radioisotopes Main Business and Markets Served

      • 11.9.4 Jubilant DraxImage Therapeutic Radioisotopes Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Curium Pharmaceuticals

      • 11.10.1 Curium Pharmaceuticals Company Details

      • 11.10.2 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Curium Pharmaceuticals Therapeutic Radioisotopes Main Business and Markets Served

      • 11.10.4 Curium Pharmaceuticals Therapeutic Radioisotopes Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Lantheus

      • 11.11.1 Lantheus Company Details

      • 11.11.2 Lantheus Therapeutic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Lantheus Therapeutic Radioisotopes Main Business and Markets Served

      • 11.11.4 Lantheus Therapeutic Radioisotopes Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    12 Global Therapeutic Radioisotopes Market Outlook by Types and Applications to 2028

    • 12.1 Global Therapeutic Radioisotopes Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Radium-223 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Lutetium-177 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Iodine-131 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Therapeutic Radioisotopes Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Thyroid Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Bone Metastasis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Therapeutic Radioisotopes Market Analysis and Outlook to 2028

    • 13.1 Global Therapeutic Radioisotopes Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.2.2 Canada Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Therapeutic Radioisotopes Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.3.2 UK Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.3.3 Spain Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.3.5 France Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.3.6 Italy Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.3.8 Finland Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.3.9 Norway Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.3.11 Poland Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.3.12 Russia Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Therapeutic Radioisotopes Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.4.2 Japan Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.4.3 India Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Therapeutic Radioisotopes Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.5.3 Chile Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.5.6 Peru Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Therapeutic Radioisotopes Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.6.3 Oman Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Therapeutic Radioisotopes Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Therapeutic Radioisotopes Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Therapeutic Radioisotopes Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Therapeutic Radioisotopes Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Therapeutic Radioisotopes

    • Figure of Therapeutic Radioisotopes Picture

    • Table Global Therapeutic Radioisotopes Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Therapeutic Radioisotopes Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Radium-223 Consumption and Growth Rate (2017-2022)

    • Figure Global Lutetium-177 Consumption and Growth Rate (2017-2022)

    • Figure Global Iodine-131 Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Thyroid Consumption and Growth Rate (2017-2022)

    • Figure Global Bone Metastasis Consumption and Growth Rate (2017-2022)

    • Figure Global Lymphoma Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Therapeutic Radioisotopes Consumption by Country (2017-2022)

    • Table North America Therapeutic Radioisotopes Consumption by Country (2017-2022)

    • Figure United States Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Canada Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Mexico Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Table Europe Therapeutic Radioisotopes Consumption by Country (2017-2022)

    • Figure Germany Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure UK Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Spain Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Belgium Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure France Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Italy Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Denmark Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Finland Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Norway Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Sweden Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Poland Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Russia Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Turkey Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Table APAC Therapeutic Radioisotopes Consumption by Country (2017-2022)

    • Figure China Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Japan Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure India Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure South Korea Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Thailand Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Singapore Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Philippines Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Table South America Therapeutic Radioisotopes Consumption by Country (2017-2022)

    • Figure Brazil Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Colombia Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Chile Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Argentina Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Peru Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Table GCC Therapeutic Radioisotopes Consumption by Country (2017-2022)

    • Figure Bahrain Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Oman Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Qatar Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Table Africa Therapeutic Radioisotopes Consumption by Country (2017-2022)

    • Figure Nigeria Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure South Africa Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Egypt Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure Algeria Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Table Oceania Therapeutic Radioisotopes Consumption by Country (2017-2022)

    • Figure Australia Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Therapeutic Radioisotopes Consumption and Growth Rate (2017-2022)

    • Table Spectrum Pharmaceuticals Company Details

    • Table Spectrum Pharmaceuticals Therapeutic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Spectrum Pharmaceuticals Therapeutic Radioisotopes Main Business and Markets Served

    • Table Spectrum Pharmaceuticals Therapeutic Radioisotopes Product Portfolio

    • Table Dongcheng Company Details

    • Table Dongcheng Therapeutic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dongcheng Therapeutic Radioisotopes Main Business and Markets Served

    • Table Dongcheng Therapeutic Radioisotopes Product Portfolio

    • Table Q BioMed Company Details

    • Table Q BioMed Therapeutic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Q BioMed Therapeutic Radioisotopes Main Business and Markets Served

    • Table Q BioMed Therapeutic Radioisotopes Product Portfolio

    • Table Bayer Company Details

    • Table Bayer Therapeutic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Therapeutic Radioisotopes Main Business and Markets Served

    • Table Bayer Therapeutic Radioisotopes Product Portfolio

    • Table International Isotopes Company Details

    • Table International Isotopes Therapeutic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table International Isotopes Therapeutic Radioisotopes Main Business and Markets Served

    • Table International Isotopes Therapeutic Radioisotopes Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Therapeutic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Therapeutic Radioisotopes Main Business and Markets Served

    • Table Novartis Therapeutic Radioisotopes Product Portfolio

    • Table China Isotope & Radiation Company Details

    • Table China Isotope & Radiation Therapeutic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table China Isotope & Radiation Therapeutic Radioisotopes Main Business and Markets Served

    • Table China Isotope & Radiation Therapeutic Radioisotopes Product Portfolio

    • Table Progenics Pharmaceuticals Company Details

    • Table Progenics Pharmaceuticals Therapeutic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Progenics Pharmaceuticals Therapeutic Radioisotopes Main Business and Markets Served

    • Table Progenics Pharmaceuticals Therapeutic Radioisotopes Product Portfolio

    • Table Jubilant DraxImage Company Details

    • Table Jubilant DraxImage Therapeutic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jubilant DraxImage Therapeutic Radioisotopes Main Business and Markets Served

    • Table Jubilant DraxImage Therapeutic Radioisotopes Product Portfolio

    • Table Curium Pharmaceuticals Company Details

    • Table Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Curium Pharmaceuticals Therapeutic Radioisotopes Main Business and Markets Served

    • Table Curium Pharmaceuticals Therapeutic Radioisotopes Product Portfolio

    • Table Lantheus Company Details

    • Table Lantheus Therapeutic Radioisotopes Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lantheus Therapeutic Radioisotopes Main Business and Markets Served

    • Table Lantheus Therapeutic Radioisotopes Product Portfolio

    • Figure Global Radium-223 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lutetium-177 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Iodine-131 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Thyroid Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bone Metastasis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Therapeutic Radioisotopes Consumption Forecast by Country (2022-2028)

    • Table North America Therapeutic Radioisotopes Consumption Forecast by Country (2022-2028)

    • Figure United States Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Therapeutic Radioisotopes Consumption Forecast by Country (2022-2028)

    • Figure Germany Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Therapeutic Radioisotopes Consumption Forecast by Country (2022-2028)

    • Figure China Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Therapeutic Radioisotopes Consumption Forecast by Country (2022-2028)

    • Figure Brazil Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Therapeutic Radioisotopes Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Therapeutic Radioisotopes Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Therapeutic Radioisotopes Consumption Forecast by Country (2022-2028)

    • Figure Australia Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Therapeutic Radioisotopes Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US